Go2 Foundation for Lung Cancer

Analysis

Go2 Foundation for Lung Cancer is a registered charity in United States, based in Washington, DC. It received its IRS tax-exemption ruling in September 2006, 20 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Go2 Foundation for Lung Cancer reported income of $12.8m and spending of $13.8m, spending 108% of what it took in. Across the 6 years on record, from December 2018 to December 2023, income grew from $5.3m to $12.8m (+141%), an average of +19% a year. The sharpest change came in the year to December 2020, when income rose by 64%. Over the whole period it spent 93% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Go2 Foundation for Lung Cancer sits at the 86th percentile: it is larger than about 86% of them. Against every charity in United States with reported income it ranks in the 96th percentile, and in the 89th percentile within DC. Charities of a similar size with the same main cause include Floyd-Polk Healthcare Foundation Inc ($12.8m), First Choice Services Inc ($12.8m) and Danvers Management Systems Inc ($12.8m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 96% and program service revenue 2.4% of the total. Compensation of current officers, directors and key employees was $1.9m (14% of expenses). Other salaries and wages came to $4.0m. It paid $17 in professional fundraising fees. At year end it held assets of $21.0m against liabilities of $4.7m, net assets of $16.2m. It reported 62 employees.